Breast cancer risk for women with diabetes and the impact of metformin: A meta-analysis.

Yifan LuAli HajjarVincent L CrynsAmy Trentham-DietzRonald E GangnonBrandy M Heckman-StoddardOguzhan Alagoz

Published in: Cancer medicine (2022)

These two meta-analyses can inform decision-making for women with type 2 diabetes regarding their use of metformin and the use of screening mammography for early detection of breast cancer.

Keyphrases

breast cancer risk
meta analyses
decision making
systematic review
type diabetes
cardiovascular disease
randomized controlled trial
glycemic control
contrast enhanced
magnetic resonance imaging
computed tomography
pregnant women
skeletal muscle
weight loss